Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,732 | 242 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $971.54 | 80 | $0 (2024) |
| ABBVIE INC. | $700.05 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $275.21 | 17 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $258.69 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $238.59 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $192.11 | 11 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $149.32 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $134.00 | 6 | $0 (2024) |
| GENZYME CORPORATION | $130.71 | 6 | $0 (2024) |
| PFIZER INC. | $92.77 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $578.84 | 31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($114.99) |
| 2023 | $1,787 | 110 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($369.15) |
| 2022 | $466.58 | 30 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($167.35) |
| 2021 | $900.13 | 71 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($320.05) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: LIVER DISEASE | ||||||
| 11/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: VIROLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Gastroenterology | ||||||
| 05/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Gastroenterology | ||||||
| 04/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Gastroenterology | ||||||
| 04/02/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Gastroenterology | ||||||
| 03/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 02/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 02/20/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: VIROLOGY | ||||||
| 02/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Immunology | ||||||
| 01/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Gastroenterology | ||||||
| 01/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 382 | 445 | $63,362 | $22,178 |
| 2022 | 4 | 343 | 417 | $54,538 | $16,827 |
| 2021 | 6 | 702 | 901 | $90,130 | $35,467 |
| 2020 | 7 | 624 | 768 | $59,398 | $18,868 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 104 | 130 | $18,980 | $7,961 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 162 | 191 | $18,874 | $7,024 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 30 | $7,800 | $2,092 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 39 | 39 | $5,290 | $1,755 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 27 | $5,346 | $1,229 | 23.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,936 | $1,091 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $3,136 | $1,026 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 231 | 287 | $32,490 | $10,107 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 36 | 47 | $8,230 | $2,816 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 34 | 34 | $5,660 | $1,685 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 33 | $6,014 | $1,472 | 24.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 16 | $2,144 | $746.28 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 338 | 471 | $53,530 | $20,392 | 38.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 56 | 56 | $8,368 | $3,600 | 43.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 158 | 195 | $7,410 | $3,228 | 43.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 54 | $7,236 | $2,543 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 51 | $5,522 | $2,042 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 27 | $4,398 | $1,855 | 42.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 42 | 47 | $3,666 | $1,805 | 49.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 296 | 403 | $15,314 | $6,795 | 44.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 167 | 195 | $23,738 | $5,773 | 24.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 49 | 49 | $7,894 | $2,158 | 27.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 29 | 29 | $2,262 | $966.00 | 42.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 29 | $3,142 | $859.23 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 11 | 11 | $2,062 | $649.44 | 31.5% |
About Ashlee Eichenlaub, APRN
Ashlee Eichenlaub, APRN is a Family healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1376083857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashlee Eichenlaub, APRN has received a total of $3,732 in payments from pharmaceutical and medical device companies, with $578.84 received in 2024. These payments were reported across 242 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,732).
As a Medicare-enrolled provider, Eichenlaub has provided services to 2,051 Medicare beneficiaries, totaling 2,531 services with total Medicare billing of $93,340. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Ashland, KY
- Active Since 03/02/2017
- Last Updated 03/03/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1376083857
Products in Payments
- XIFAXAN (Drug) $664.50
- DUPIXENT (Biological) $389.40
- TRULANCE (Drug) $307.04
- ENTYVIO (Biological) $226.35
- MAVYRET (Drug) $217.28
- STELARA (Biological) $197.89
- DIFICID (Drug) $192.11
- Linzess (Drug) $149.32
- LINZESS (Drug) $143.21
- RINVOQ (Biological) $93.25
- CREON (Drug) $82.73
- XELJANZ (Drug) $81.50
- REBYOTA (Biological) $79.90
- REMICADE (Biological) $77.32
- Wegovy (Drug) $68.96
- ZENPEP (Drug) $68.69
- VIBERZI (Drug) $58.35
- SKYRIZI (Biological) $55.94
- HUMIRA (Biological) $49.29
- RESMETIROM (Drug) $42.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ashland
Mr. Stephen Perkey, Cnp, CNP
Family — Payments: $28,660
Ashley Malone, Msn, Rn, Fnp-Bc, MSN, RN, FNP-BC
Family — Payments: $9,852
Jessica Hicks, Aprn, APRN
Family — Payments: $9,119
Eva Joseph, Aprn, APRN
Family — Payments: $7,607
Brittany Linn
Family — Payments: $7,278
Ms. Brenda Sawyer, Lnp, LNP
Family — Payments: $6,342